Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Auris Browne"'
Autor:
Tiffany R. Bellomo, Yuxi Liu, Thomas C. Gilliland, Hannah Miksenas, Sara Haidermota, Megan Wong, Xingdi Hu, Joaquim Rosado Cristino, Auris Browne, Jorge Plutzky, Sotirios Tsimikas, James L. Januzzi, Jr., Pradeep Natarajan
Publikováno v:
Journal of Lipid Research, Vol 65, Iss 7, Pp 100585- (2024)
The roles of lipoprotein(a) [Lp(a)] and related oxidized phospholipids (OxPLs) in the development and progression of coronary disease is known, but their influence on extracoronary vascular disease is not well-established. We sought to evaluate assoc
Externí odkaz:
https://doaj.org/article/656f0ededc1c4728a7450433adac033e
Autor:
James L. Januzzi, Roland R. J. van Kimmenade, Yuxi Liu, Xingdi Hu, Auris Browne, Jorge Plutzky, Sotirios Tsimikas, Ron Blankstein, Pradeep Natarajan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 12 (2024)
Background Higher lipoprotein(a) and oxidized phospholipid concentrations are associated with increased risk for coronary artery disease and valvular heart disease. The role of lipoprotein(a) or oxidized phospholipid as a risk factor for incident hea
Externí odkaz:
https://doaj.org/article/c929cc04d11a40d19183551f02d71323
Autor:
Michael D. Shapiro, Tariq M. Haddad, Howard S. Weintraub, Seth J. Baum, Khaled AbdulNour, Vadim Paluy, Wess Boatwright, Auris Browne, Imran Ayaz, Cheryl A. Abbas, Christie M. Ballantyne
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100552- (2023)
Therapeutic Area: ASCVD/CVD Risk Reduction Background: Elevated lipoprotein(a) [Lp(a)] is the most common inherited dyslipidemia leading to an increased risk of atherosclerotic cardiovascular disease (ASCVD). Several cohort studies have reported elev
Externí odkaz:
https://doaj.org/article/8d7dd21bc5624b9791f2cab6f92bbfb4
Autor:
Thomas C. Gilliland, Yuxi Liu, Reza Mohebi, Hannah Miksenas, Sara Haidermota, Megan Wong, Xingdi Hu, Joaquim Rosado Cristino, Auris Browne, Jorge Plutzky, Sotirios Tsimikas, James L. Januzzi, Pradeep Natarajan
Publikováno v:
Journal of the American College of Cardiology. 81:1780-1792
Autor:
Michael D. Shapiro, Tariq Haddad, Howard S. Weintraub, Seth J. Baum, Khaled Abdul-Nour, Vadim Paluy, Wess Boatwright, Auris Browne, Imran Ayaz, Xiangyi Meng, Cheryl A. Abbas, Christie M. Ballantyne
Publikováno v:
Journal of the American College of Cardiology. 81:1633
Publikováno v:
Am J Cardiol
The relation between elevated lipoprotein(a) and total atherosclerotic cardiovascular disease (ASCVD) residual risk in persons with known cardiovascular disease on statin therapy is not well-established. We examined first and total recurrent ASCVD ev
Publikováno v:
Diabetes. 69
Background: The relation between elevated lipoprotein(a) [Lp(a)] and future atherosclerotic cardiovascular disease (ASCVD) in those with vs. without diabetes mellitus (DM) but known cardiovascular disease (CVD) is not clear. We examined recurrent ASC
Publikováno v:
Journal of the American College of Cardiology. 75:1847
The relation between elevated lipoprotein(a) [Lp(a)] with total ASCVD residual risk specially in persons with known ASCVD on statin therapy is not well-established. We examined the first and total recurrent ASCVD risk among this population using the
Autor:
Omar Saeed, Jooyoung J. Shin, Auris Browne, Philip Formica, Simon Maybaum, Vivek Bhatia, Thomas K. Aldrich
Publikováno v:
Journal of Cardiac Failure. 18:387-391
Background Adaptation to altitude leads to beneficial physiologic changes that improve oxygen delivery and utilization by the periphery. Athletes have used simulated altitude enclosures as part of their training regimen to improve exercise performanc
Autor:
Marie Galvao, Simon Maybaum, J. Immekus, Nadia Fida, Auris Browne, Omar Saeed, Daniel J. Goldstein
Publikováno v:
The Journal of Heart and Lung Transplantation. 32:S131-S132
Purpose Criteria for the identification of “at risk” patients with advanced heart failure (HF) have been previously suggested. However, identification of appropriate non inotrope dependent (NID) patients for Destination Therapy (DT) remains a cha